Sven Lindner
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Protein Degradation and Inhibitors, CAR-T cell therapy research, Ubiquitin and proteasome pathways, Chromatin Remodeling and Cancer
Most-Cited Works
- → LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression(2012)384 cited
- → Histone deacetylase 10 promotes autophagy-mediated cell survival(2013)212 cited
- → Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice(2012)178 cited
- → Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2015)178 cited
- → Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation(2015)99 cited
- → Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment(2015)84 cited
- → miR‐542‐3p exerts tumor suppressive functions in neuroblastoma by downregulating S urvivin(2014)83 cited
- → The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models(2016)44 cited
- → Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells(2014)37 cited
- → Absence of telomerase reverse transcriptase promoter mutations in neuroblastoma(2015)31 cited